| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |